Animal Testing Alternatives: New FDA Guidance Insights
Learn how Animal Testing Alternatives can accelerate R&D and improve human relevance in safety data and drug development.
FDA Biosimilar Development Guidance Targets Treatment Costs
Learn how the new FDA biosimilar development guidance can significantly lower biologic medicine costs and improve accessibility.
FDA Unpredictable: Moderna Challenges the Agency
Moderna criticises the FDA as unpredictable, impacting its mRNA flu shot and the future of drug innovation in America.
FDA Generic Drug Review Boosts US Drug Manufacturing
The US Food and Drug Administration (FDA) has announced the launch of a new pilot programme. This programme aims to accelerate the review process for generic drugs. Companies research, develop, and manufacture these drugs entirely within the United States…. Membership Required You must be a member to access this content.View Membership LevelsAlready a member? Log...
HHS Restructuring Plan Blocked by Federal Court
The HHS restructuring plan faced a major setback as the court intervened, stopping job cuts and agency overhaul efforts.
Are New Cancer Treatments Worth the Price?
Learn about the cost of cancer treatments and the reality behind their effectiveness. Are patients getting the care they deserve?
FDA warns Aspen Pharmacare over eye drop production standards
The US FDA has warned Aspen Pharmacare, Africa's largest drugmaker, citing breaches in manufacturing standards for eye drops produced at its Gqeberha facility.